Larvol Delta - BioThera-Solutions-and-Hikma-Pharmaceuticals-Announce-Exclusive-Commercialization-and-License-Agreement-for-BAT2206-in-the-US-a-Proposed-Biosimilar-Referencing-Stelara-ustekinumab

BAT2206 (ustekinumab biosimilar) - Bio-Thera Solutions

https://www.businesswire.com/news/home/20210827005059/en/Bio-Thera-Solutions-and-Hikma-Pharmaceuticals-Announce-Exclusive-Commercialization-and-License-Agreement-for-BAT2206-in-the-US-a-Proposed-Biosimilar-Referencing-Stelara%C2%AE-ustekinumab

Aug 27, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next